Back to MW MARSHALL WACE, LLP

GLUEGLUE
8 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MONTE ROSA THERAPEUTICS INC

MARSHALL WACE, LLP holds 1.6M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $38.6M as of 2026-Q2. The position was increased (+11.2% shares). GLUE represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$38.6M

Current Shares

1.6M

Total Value Change

+$37.6M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+11.2%
$38.6M0.0%$24.20
32
2026-Q1
Increased
1.4M
+259.3%
$23.6M0.0%$17.96
46
2025-Q4
Decreased
398,890
-55.8%
$6.3M0.0%$15.97
0
2025-Q3
Increased
902,834
+102.4%
$6.7M0.0%$7.31
44
2025-Q2
Increased
446,080
+20.0%
$2M0.0%$4.60
31
2025-Q1
Decreased
371,738
-25.6%
$1.7M0.0%$5.10
0
2024-Q4
Increased
499,492
+187.3%
$3.5M0.0%$7.02
43
2024-Q3
New
173,849
-
$921,4000.0%$5.17
35

Other major holders of GLUE: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used